Neurophysiological predictors of long term response to AChE inhibitors in AD patients
Open Access
- 1 August 2005
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (8), 1064-1069
- https://doi.org/10.1136/jnnp.2004.051334
Abstract
Background: In vivo evaluation of cholinergic circuits of the human brain has recently been introduced using a transcranial magnetic stimulation (TMS) protocol based on coupling peripheral nerve stimulation with motor cortex TMS (short latency afferent inhibition, SAI). SAI is reduced in Alzheimer’s disease (AD) and drugs enhancing cholinergic transmission increase SAI. Methods: We evaluated whether SAI testing, together with SAI test-retest, after a single dose of the acetylcholinesterase (AChE) inhibitor rivastigmine, might be useful in predicting the response after 1 year treatment with rivastigmine in 16 AD patients. Results: Fourteen AD patients had pathologically reduced SAI. SAI was increased after administration of a single oral dose of rivastigmine in AD patients with abnormal baseline SAI, but individual responses to rivastigmine varied widely, with SAI change ranging from an increase in inhibition of ∼50% of test size to no change. Baseline SAI and the increase in SAI after a single dose of rivastigmine were correlated with response to long term treatment. A normal SAI in baseline conditions, or an abnormal SAI in baseline conditions that was not greatly increased by a single oral dose of rivastigmine, were invariably associated with poor response to long term treatment, while an abnormal SAI in baseline conditions in conjunction with a large increase in SAI after a single dose of rivastigmine was associated with good response to long term treatment in most of the patients. Conclusions: Evaluation of SAI may be useful for identifying AD patients likely to respond to treatment with AChE inhibitors.Keywords
This publication has 20 references indexed in Scilit:
- Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapyActa Neurologica Scandinavica, 2009
- Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2004
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999
- CENTRAL CHOLINERGIC SYSTEMS AND COGNITIONAnnual Review of Psychology, 1997
- Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation studyAnnals of Neurology, 1996
- Effects of cholinergic blockade on language in healthy young womenBrain, 1994
- Double Dissociation Between Temporal and Spatial Pattern Processing in Patients with Frontal and Parietal DamageCortex, 1990
- Global Deterioration Scale (GDS).1988
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- The assessment and analysis of handedness: The Edinburgh inventoryNeuropsychologia, 1971